0001181431-13-013362.txt : 20130228
0001181431-13-013362.hdr.sgml : 20130228
20130228170824
ACCESSION NUMBER: 0001181431-13-013362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130227
FILED AS OF DATE: 20130228
DATE AS OF CHANGE: 20130228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANGECKER PETER
CENTRAL INDEX KEY: 0001282829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21990
FILM NUMBER: 13653328
MAIL ADDRESS:
STREET 1: C/O INTARCIA THERAPEUTICS, INC.
STREET 2: 2000 POWELL ST., SUITE 1640
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OXIGENE INC
CENTRAL INDEX KEY: 0000908259
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 133679168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-635-7000
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
rrd372254.xml
X0306
4
2013-02-27
0
0000908259
OXIGENE INC
OXGN
0001282829
LANGECKER PETER
C/O OXIGENE, INC.
701 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
4.18
2013-02-27
4
A
0
8333
0
A
2023-02-27
Common Stock
8333
8333
D
The Stock Option vests semi-annually in eight equal installments of 12.5% of the number of stock options granted beginning on August 27, 2013, six months following the grant date.
/s/ Megan N. Gates, attorney-in-fact
2013-02-28